GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (FRA:1RT) » Definitions » Total Payout Ratio

Nuformix (FRA:1RT) Total Payout Ratio : 0.62 (As of Dec. 14, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Nuformix Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Nuformix's current Total Payout Ratio is 0.62.


Nuformix Total Payout Ratio Historical Data

The historical data trend for Nuformix's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuformix Total Payout Ratio Chart

Nuformix Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Total Payout Ratio
Get a 7-Day Free Trial 1.07 - 1.77 1.60 0.13

Nuformix Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Mar24
Total Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.21 0.62 -0.11 0.62

Competitive Comparison of Nuformix's Total Payout Ratio

For the Biotechnology subindustry, Nuformix's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nuformix's Total Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nuformix's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Nuformix's Total Payout Ratio falls into.



Nuformix Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Nuformix's Total Payout Ratio for the fiscal year that ended in Mar. 2022 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 0.167 + 0) / -1.327
=0.13

Nuformix's Total Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 0.175 + 0) / -0.284
=0.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nuformix Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Nuformix's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuformix Business Description

Traded in Other Exchanges
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.

Nuformix Headlines

No Headlines